medigraphic.com
SPANISH

Revista Mexicana de Trasplantes

ISSN 3122-3893 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 2

<< Back Next >>

Rev Mex Traspl 2026; 15 (2)

Prevalence of acute kidney injury in liver transplantation and its association with risk factors in Hospital de Especialidades del Centro Médico Nacional La Raza

Canedo-Castillo NA, Gómez-Sánchez E, Mendoza-Mendoza GJ
Full text How to cite this article 10.35366/124002

DOI

DOI: 10.35366/124002
URL: https://dx.doi.org/10.35366/124002

Language: Spanish
References: 17
Page: 68-77
PDF size: 889.66 Kb.


Key words:

acute kidney injury, orthotopic liver transplantation, ischemia-reperfusion syndrome, renal replacement therapy.

ABSTRACT

Introduction: liver transplantation is a condition that alters the survival of patients with advanced cirrhosis. One of the main post-surgical complications is acute kidney injury (AKI), with a prevalence between 15% and 95%, which directly affects the length of stay in the ICU and is related to mortality. There are various pre-transplant, surgical, and post-surgical risk factors. Objective: to calculate the prevalence of AKI in liver transplant recipients treated in the intensive care unit and to determine the most important risk factors associated with AKI in these patients. Material and methods: this was an observational, retrospective, cross-sectional, single-center study with a 6-year exposure period. It included 77 liver transplant recipients. A bivariate analysis was performed comparing patients with and without AKI. Robot variance analysis (ROC): sensitivity and specificity were determined for risk factors with a p-value ‹ 0.20. Results: the observed prevalence was 62.3%. Grade 2 AKI was the most prevalent in our population at 24.6%. 12.9% required continuous renal replacement therapy. Furosemide was the most significant pre-surgical risk factor. The most frequent comorbidity was diabetes mellitus. Ischemia-reperfusion syndrome occurred in 66% of patients, and 48% were associated with AKI. Conclusions: the SOFA score is related to the presence and severity of AKI, and AKI is correlated with the length of stay in the ICU.


REFERENCES

  1. Aguirre-Villarreal D, García-Juárez I, García-Juárez FI,Paez-Zayas VM, Sánchez-Cedillo A. Una visión generaldel trasplante hepático en México. Rev Gastro Mex[Internet]. 2024; 89 (3): 1-3. Disponible en: https://www.revistagastroenterologiamexico.org/es-una-vision-general-deltrasplante-articulo-S0375090624000624

  2. Aguirre-Villarreal D, Servin-Rojas M, Sánchez-Cedillo A et al.Liver transplantation in Latin America: reality and challenges.Lancet Reg Health Am. 2023; 28: 100633. doi: 10.1016/j.lana.2023.100633.

  3. Centro Nacional de Trasplantes (CENATRA). Estadísticas sobredonación y trasplantes [Internet]. Ciudad de México: Secretaríade Salud; 2025. Disponible en: https://www.gob.mx/cenatra/documentos/estadisticas-50060

  4. Hoppmann N, Massoud O. Medical care of liver transplantpatients. Expert Rev Gastroenterol Hepatol. 2020; 14 (10): 901-918. doi: 10.1080/17474124.2020.1797483.

  5. Dong V, Nadim MK, Karvellas CJ. Post-liver transplant acutekidney injury. Liver Transpl. 2021; 27 (11): 1653-1664. doi:10.1002/lt.26094.

  6. Thongprayoon C, Kaewput W, Thamcharoen N, Bathini T,Watthanasuntorn K, Lertjitbanjong P et al. Incidence and impactof acute kidney injury after liver transplantation: a meta-analysis.J Clin Med. 2019; 8 (3): 372. doi: 10.3390/jcm8030372.

  7. Barreto AG, Daher EF, Silva Junior GB et al. Risk factors for acutekidney injury and 30-day mortality after liver transplantation. AnnHepatol. 2015; 14 (5): 688-694.

  8. Sanchez EQ, Gonwa TA, Levy MF et al. Preoperative andperioperative predictors of the need for renal replacement therapyafter orthotopic liver transplantation. Transplantation. 2004; 78(7): 1048-1054. doi: 10.1097/01.tp.0000137176.95730.5b.

  9. Zhou J, Zhang X, Lyu L, Ma X, Miao G, Chu H. Modifiablerisk factors of acute kidney injury after liver transplantation: asystematic review and meta-analysis. BMC Nephrol. 2021; 22(1): 149. doi: 10.1186/s12882-021-02360-8.

  10. Tokodai K, Lannsjo C, Kjaernet F et al. Association of postreperfusionsyndrome and ischemia-reperfusion injury withacute kidney injury after liver transplantation. Acta AnaesthesiolScand. 2020; 64 (6): 742-750. doi: 10.1111/aas.13556.

  11. Schmitz V, Schoening W, Jelkmann I et al. Different cavareconstruction techniques in liver transplantation: piggybackversus cava resection. Hepatobiliary Pancreat Dis Int. 2014; 13(3): 242-249. doi: 10.1016/s1499-3872(14)60250-2.

  12. Durand F, Francoz C, Asrani SK et al. Acute kidney injury afterliver transplantation. Transplantation. 2018; 102 (10): 1636-1649. doi: 10.1097/TP.0000000000002305.

  13. Zarbock A, Weiss R, Albert F et al. Epidemiology of surgeryassociated acute kidney injury (EPIS-AKI): a prospective internationalobservational multi-center clinical study. Intensive Care Med. 2023;49 (12): 1441-1455. doi: 10.1007/s00134-023-07169-7.

  14. Section 2: AKI definition. Kidney Int Suppl (2011). 2012; 2 (1):19-36. doi: 10.1038/kisup.2011.32.

  15. Straus C, Booke H, Forni L, Zarbock A. Biomarkers ofacute kidney injury: From discovery to the future of clinicalpractice. J Clin Anesth. 2024; 95: 111458. doi: 10.1016/j.jclinane.2024.111458.

  16. Wu H, Liu K, Darko IN et al. Predictive value of renal resistiveindex for the onset of acute kidney injury and its non-recovery: asystematic review and meta-analysis. Clin Nephrol. 2020; 93 (4): 172-186. doi: 10.5414/CN109979.

  17. Shankar V, Raj A, Singhal S et al. Doppler-derived renal resistiveindex helps predict acute kidney injury in patients undergoingliving-related liver transplantation. Clin Transplant. 2021; 35 (5):e14263. doi: 10.1111/ctr.14263.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Traspl. 2026;15